CN1144488A - 新型呼吸道病毒性疾病治疗药物 - Google Patents

新型呼吸道病毒性疾病治疗药物 Download PDF

Info

Publication number
CN1144488A
CN1144488A CN95192216A CN95192216A CN1144488A CN 1144488 A CN1144488 A CN 1144488A CN 95192216 A CN95192216 A CN 95192216A CN 95192216 A CN95192216 A CN 95192216A CN 1144488 A CN1144488 A CN 1144488A
Authority
CN
China
Prior art keywords
virus
viral diseases
alp
clara
treating viral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN95192216A
Other languages
English (en)
Chinese (zh)
Inventor
木户博
田代真人
关户祥三郎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Pharma Corp
Original Assignee
Tokyo Tanabe Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tokyo Tanabe Co Ltd filed Critical Tokyo Tanabe Co Ltd
Publication of CN1144488A publication Critical patent/CN1144488A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
CN95192216A 1994-03-23 1995-03-20 新型呼吸道病毒性疾病治疗药物 Pending CN1144488A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP52237/94 1994-03-23
JP5223794 1994-03-23

Publications (1)

Publication Number Publication Date
CN1144488A true CN1144488A (zh) 1997-03-05

Family

ID=12909121

Family Applications (1)

Application Number Title Priority Date Filing Date
CN95192216A Pending CN1144488A (zh) 1994-03-23 1995-03-20 新型呼吸道病毒性疾病治疗药物

Country Status (16)

Country Link
US (1) US5900401A (enExample)
EP (1) EP0804930A1 (enExample)
KR (1) KR970701561A (enExample)
CN (1) CN1144488A (enExample)
AU (1) AU689559B2 (enExample)
BG (1) BG100835A (enExample)
BR (1) BR9507165A (enExample)
CA (1) CA2186111A1 (enExample)
CZ (1) CZ265896A3 (enExample)
FI (1) FI963753A0 (enExample)
HU (1) HUT75660A (enExample)
NZ (1) NZ282488A (enExample)
PL (1) PL316444A1 (enExample)
RO (1) RO113431B1 (enExample)
SK (1) SK119896A3 (enExample)
WO (1) WO1995025539A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69810800T2 (de) * 1997-10-07 2003-09-18 Boehringer Ingelheim (Canada) Ltd., Laval Azetidinonderivate zur behandlung von hcmv entzündungen
DE69810651T2 (de) * 1997-10-07 2003-08-21 Boehringer Ingelheim (Canada) Ltd., Laval Azetidinonderivate zur behandlung von hcmv entzündungen
DK1021405T3 (da) * 1997-10-07 2003-02-03 Boehringer Ingelheim Ca Ltd Azetidinonderivater til behandling af HCMV-infektioner
US8679462B2 (en) * 2002-04-11 2014-03-25 Saeed Rezakhany Methods of preventing respiratory infections
AU2021235223A1 (en) * 2020-03-09 2022-09-29 Denis Barritault Composition for the treatment of lesions of the respiratory system

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0182906A1 (en) * 1984-06-14 1986-06-04 Cortech, Inc. Human leukocyte elastase inhibitors prepared from pyogenic bacteria and methods for their purification
WO1986003497A1 (en) * 1984-12-06 1986-06-19 Synergen Biologicals, Inc. Serine protease inhibitors and methods for isolation of same
IL95223A (en) * 1984-12-06 1992-08-18 Synergen Biolog Inc Dna sequence for production of serine protease inhibitors
JPS62501291A (ja) * 1984-12-06 1987-05-21 サイナ−ゲン　バイオロジカルズ，インコ−ポレ−テツド 精製セリンプロテアーゼインヒビターおよびこれを含有する医薬組成物
US4760130A (en) * 1984-12-06 1988-07-26 Synergen Biologicals, Inc. Serine protease inhibitors and methods for isolation of same
DE3600571A1 (de) * 1986-01-10 1987-08-06 Gruenenthal Gmbh Dna-sequenzen, die fuer proteine mit der biologischen aktivitaet der husi-typi-inhibitoren codieren, gentechnologische verfahren zur herstellung dieser proteine und diese proteine enthaltende arzneimittel
US5290762A (en) * 1986-12-24 1994-03-01 John Lezdey Treatment of inflammation
CA1340877C (en) * 1987-12-28 2000-01-18 Takashi Sugiyama Elastase inhibitory polypeptide and process for production thereof by recombinant gene technology
DE3841873A1 (de) * 1988-12-13 1990-06-21 Gruenenthal Gmbh Neue serinprotease-inhibitor-proteine, diese enthaltende arzneimittel, dna-sequenzen, die fuer diese proteine codieren und verfahren zur herstellung dieser proteine, arzneimittel und dna-sequenzen
JP3961029B2 (ja) * 1992-06-24 2007-08-15 博 木戸 インフルエンザウィルス感染防止剤
US5334141A (en) * 1992-06-26 1994-08-02 Medrad, Inc. Extravasation detection system and apparatus
EP0666755B1 (en) * 1992-09-09 2003-04-23 Amgen Inc. Inhibition of hiv-infection
US5376633A (en) * 1992-09-30 1994-12-27 Lezdey; John Method for deactivating viruses in blood component containers
US5633227A (en) * 1994-09-12 1997-05-27 Miles, Inc. Secretory leukocyte protease inhibitor as an inhibitor of tryptase

Also Published As

Publication number Publication date
US5900401A (en) 1999-05-04
SK119896A3 (en) 1997-04-09
NZ282488A (en) 1999-09-29
WO1995025539A1 (en) 1995-09-28
HUT75660A (en) 1997-05-28
FI963753L (fi) 1996-09-20
RO113431B1 (ro) 1998-07-30
BR9507165A (pt) 1997-09-09
EP0804930A1 (en) 1997-11-05
KR970701561A (ko) 1997-04-12
BG100835A (bg) 1997-06-30
AU1961195A (en) 1995-10-09
AU689559B2 (en) 1998-04-02
PL316444A1 (en) 1997-01-20
CA2186111A1 (en) 1995-09-28
EP0804930A4 (enExample) 1997-11-05
CZ265896A3 (en) 1997-06-11
FI963753A7 (fi) 1996-09-20
HU9602598D0 (en) 1996-11-28
FI963753A0 (fi) 1996-09-20

Similar Documents

Publication Publication Date Title
JP7116823B2 (ja) 新規なトリプシンアイソフォームおよびそれらの使用
US6406698B1 (en) Pharmaceutical composition comprising serum amyloid P component for prophylactic or therapeutic treatment of virus infections and a kit for detecting binding of compositions to virus components
AU2021211012A1 (en) Methods, compositions, and vaccines for treating a virus infection
US6713069B1 (en) Compositions and methods for detecting, preventing, and treating African Hemorrhagic Fever
HUE030838T2 (en) Recombinant human CC10 for treatment of influenza
JPH06507386A (ja) 治療用ペプチド
CN1144488A (zh) 新型呼吸道病毒性疾病治疗药物
CN111012736A (zh) 一种阻断新型冠状病毒2019-nCov的无菌喷剂敷料的应用
US20020111305A1 (en) Antiviral peptides
EP1596851B1 (en) The use of sodium 2-mercaptoethanesulfonate as antiviral agent
MXPA96004207A (en) Novedous remedy for tractor pyrrato viral disease
JPWO1995025539A1 (ja) 新規気道部ウイルス疾患治療剤
CN118267451A (zh) 一种基于病毒阻断剂的鼻腔清洗喷雾剂及其用途
Priadharsini et al. Lung Recruitability in COVID-19
Yves SARS-CoV-2 Covid 19 Spikes Chemical Reaction with Climate Humidity
CN116531509A (zh) 一种基于天然萘醌的药物组合物及应用
JPWO1997003694A1 (ja) ウイルス疾患治療剤

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C53 Correction of patent of invention or patent application
CB02 Change of applicant information

Applicant after: Mitsubishi Pharmaceutical Co., Ltd.

Applicant before: Tokyo Tanabe Co., Ltd.

COR Change of bibliographic data

Free format text: CORRECT: APPLICANT; FROM: TOKYO TANABE CO., LTD. TO: MITSUBISHI TOKYO PHARMACEUTICAL CO., LTD.

C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication